Santen Pharmaceutical Co., Ltd.

Santen Pharmaceutical Co., Ltd. - Enterprise Valueverified

SNPHF

Price:

$10.99

Market Cap:

$602.84B

Santen Pharmaceutical Co., Ltd. is a global enterprise specializing in the research, development, manufacturing, and commercialization of pharmaceuticals and medical devices. Headquartered in Osaka, Japan, its core focus lies in ophthalmology. The company boasts a robust pipeline of treatments for various eye conditions. For glaucoma and ocular hypertension, its offerings include DE-111 and DE-130A, both in Phase III clinical trials; DE-117, available in Japan; DE-126, currently in Phase IIb development; and DE-128, which is marketed in Europe and undergoing Phase II/III trials in the United States. Santen also addresses other ophthalmic conditions: DE-114A for allergic conjunctivitis, DE-07...[Read more]

Industry

Drug Manufacturers - General

IPO Date

2010-06-09

Stock Exchange

OTC

Ticker

SNPHF

The Enterprise Value as of June 2026 (TTM) for Santen Pharmaceutical Co., Ltd. (SNPHF) is 521.97B

According to Santen Pharmaceutical Co., Ltd.’s latest financial reports and current stock price. The company's current Enterprise Value is 521.97B. This represents a change of 3.20% compared to the average of 505.78B of the last 4 quarters.

Santen Pharmaceutical Co., Ltd. (SNPHF) Historical Enterprise Value (quarterly & annually)

How has SNPHF Enterprise Value performed in the past?

The mean historical Enterprise Value of Santen Pharmaceutical Co., Ltd. over the last ten years is 532.70B. The current 521.97B Enterprise Value has changed 9.70% with respect to the historical average. Over the past ten years (40 quarters), SNPHF's Enterprise Value was at its highest in in the September 2020 quarter at 826.05B. The Enterprise Value was at its lowest in in the September 2022 quarter at 339.36B.

Quarterly (TTM)
Annual

Average

532.70B

Median

529.86B

Minimum

415.84B

Maximum

659.53B

Santen Pharmaceutical Co., Ltd. (SNPHF) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Santen Pharmaceutical Co., Ltd. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 15.81%

Maximum Annual Enterprise Value = 659.53B

Minimum Annual Increase = -22.70%

Minimum Annual Enterprise Value = 415.84B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2026504.10B15.81%
2025435.28B-5.69%
2024461.56B10.99%
2023415.84B-3.18%
2022429.51B-22.70%
2021555.63B-15.75%
2020659.53B7.34%
2019614.41B-3.29%
2018635.32B3.17%
2017615.79B0.34%

Santen Pharmaceutical Co., Ltd. (SNPHF) Average Enterprise Value

How has SNPHF Enterprise Value performed in the past?

The current Enterprise Value of Santen Pharmaceutical Co., Ltd. (SNPHF) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

3-year avg

466.98B

5-year avg

449.26B

10-year avg

532.70B

Santen Pharmaceutical Co., Ltd. (SNPHF) Enterprise Value vs. Peers

How is SNPHF’s Enterprise Value compared to its peers?

Santen Pharmaceutical Co., Ltd.’s Enterprise Value is greater than Livzon Pharmaceutical Group Inc. (20.89B), less than Sumitomo Pharma Co., Ltd. (832.08B), less than Sumitomo Pharma Co., Ltd. (832.08B), greater than Bumrungrad Hospital Public Company Limited (144.76B), greater than Camurus AB (publ) (27.12B), greater than Siegfried Holding AG (3.45B), less than Welcia Holdings Co., Ltd. (635.50B), greater than Carl Zeiss Meditec AG (2.78B), greater than Carl Zeiss Meditec AG (2.78B), less than Ono Pharmaceutical Co., Ltd. (940.71B),

Build a custom stock screener for Santen Pharmaceutical Co., Ltd. (SNPHF) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Santen Pharmaceutical Co., Ltd. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Santen Pharmaceutical Co., Ltd. (SNPHF) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Santen Pharmaceutical Co., Ltd. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Santen Pharmaceutical Co., Ltd.'s Enterprise Value?

What is the highest Enterprise Value for Santen Pharmaceutical Co., Ltd. (SNPHF)?

What is the 3-year average Enterprise Value for Santen Pharmaceutical Co., Ltd. (SNPHF)?

What is the 5-year average Enterprise Value for Santen Pharmaceutical Co., Ltd. (SNPHF)?

How does the current Enterprise Value for Santen Pharmaceutical Co., Ltd. (SNPHF) compare to its historical average?